COVID-19 Vaccination information page
Moderna Vaccines Administered in Gila County 36,518 |
Current Vaccination Groups:
The FDA has approved the emergency use of the COVID-19 vaccine. The Gila County Health and EM COVID-19 response team is working with local health agencies and personnel to ensure proper distribution. You can find our prioritization plan below.
(The image below will show where we are currently at in each phase and which groups. We will update the highlighted groups as we move through each phase.)
![]() Haga clic en la imagen para PDF |
PSA: Gila County would like to remind you that vaccine is limited in supply. In addition, you must be a Gila County Resident in order to be vaccinated. Information will be verified, and you will be turned away and/or appointment canceled if you do not meet the criteria. While we do hope all Arizonians, who want to be vaccinated can be vaccinated, you must be a resident of the county in which you live.
Thank you for your understanding.
Upcoming Vaccine Clinics:
Postponed
In light of the recent press release from the CDC (read below) - We are following the recommendations released to us by both the CDC and the Arizona Department of Health Services, and will be pausing all Johnson and Johnson vaccines at this time until further information is released.
Please read the following Press Release from the CDC -
This is a joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
The following statement is attributed to Dr. Anne Schuchat, Principal Deputy Director of the CDC, and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research
As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.
CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.
Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following the COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.htmlexternal icon.
CDC and FDA will provide additional information and answer questions later today at a media briefing. A recording of that media call will be available on the FDA’s YouTube channel.]
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
CDC works 24/7 protecting America’s health, safety and security. Whether disease starts at home or abroad, is curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.
*Postponed*



Call Center Phone numbers:
For information and assistance regarding COVID-19 questions, you can contact our call center at:
Where can I get a vaccine?
Community Health Partners:
Click image to enlarge

Federal Retail Pharmacy Vaccine information:
Click image to enlarge
Frequently Asked Questions:
Live Q&A 01-27-2021
January 18, 2021 FAQs
(Printable PDF Click Here)

Provider education and reference materials:
https://www.cdc.gov/vaccines/covid-19/training.html
Moderna Vaccine provider Fact Sheet:
https://www.fda.gov/media/144637/download
Pfizer-BionTech COVID-19 provider Fact Sheet:
https://www.fda.gov/media/144413/download

Patient education and reference materials:
https://www.cdc.gov/vaccines/covid-19/hcp/index.html
Moderna Vaccine recipients Fact Sheet:
https://www.fda.gov/media/144638/download
Pfizer-BionTech COVID-19 patient Fact Sheet:
https://www.fda.gov/media/144414/download
COVID-19 Vaccination what to expect after?

Click picture for more info.
What is V Safe?
You will receive a card, from the provider administering your first vaccination dose and when to get your second. That card will be kept with you for your records.
You can also sign up with V-Safe and get the reminder on your phone.

Click picture for more info.
You can find more information on the Coronavirus vaccinations by visiting the following links below:
https://www.cdc.gov/vaccines/covid-19/index.html
Other resources you can check into is the Arizona State Farm Stadium, appointments can be scheduled via the ADHS website: https://www.azdhs.gov
Some pharmacies have partnered with the Federal Government and CDC to issue vaccines as well. In Arizona, the following are part of this partnership:
The Kroger Co.
Albertson Companies, Inc.
Walgreens
You can reference the CDC website for pharmacies per state: https://www.cdc.gov/vaccines/covid-19/retail-pharmacy-program/participating-pharmacies.html